ARA-290: Can It Repair Small Nerve Fibers?

ARA-290, also called cibinetide, is an investigational 11-amino-acid peptide designed from erythropoietin biology to activate tissue-protective signaling without stimulating red-blood-cell production.

In this episode, John Garrett, RN, breaks down the innate repair receptor, why ARA-290 has been studied in small-fiber neuropathy, what randomized human trials in sarcoidosis and type 2 diabetes actually found, and why objective nerve-fiber signals are interesting—but not the same thing as an approved therapy.

You'll learn:

• What ARA-290/cibinetide is

• How it differs from full-length erythropoietin

• What the innate repair receptor is

• Why researchers studied corneal nerve fibers

• What the 22-patient pilot trial showed

• What the 64-patient phase 2b trial showed

• Why pain and nerve-fiber endpoints did not tell exactly the same story

• What is known—and not known—about safety

• Why online ARA-290 products should not be assumed equivalent to trial material